Back to Search
Start Over
Evaluation of the combined use of adiponectin and C-reactive protein levels as biomarkers for predicting the deterioration in glycaemia after a median of 5.4 years
- Source :
- Diabetologia
- Publication Year :
- 2011
- Publisher :
- Springer-Verlag, 2011.
-
Abstract
- Aims/hypothesis: Hypoadiponectinaemia and raised C-reactive protein (CRP) level are obesity-related biomarkers associated with glucose dysregulation. We evaluated the combined use of these two biomarkers in predicting the deterioration of glycaemia in a prospective study after a median of 5.4 years. Methods: In total 1,288 non-diabetic participants from the Hong Kong Cardiovascular Risk Factor Prevalence Study-2, with high-sensitivity CRP (hsCRP) and total adiponectin levels measured were included. OGTT was performed in all participants. Two hundred and six participants had deterioration of glycaemia at follow-up, whereas 1,082 participants did not. Results: Baseline age, hsCRP and adiponectin levels were significant independent predictors of the deterioration of glycaemia in a Cox regression analysis after adjusting for baseline age, sex, BMI, hypertension, triacylglycerols, 2 h post-OGTT glucose and homeostasis model assessment of insulin resistance index (all p < 0.01). The introduction of hsCRP or adiponectin level to a regression model including the other biomarker improved the prediction of glycaemic progression significantly in all participants, especially in women (all p < 0.01). The combined inclusion of the two biomarkers resulted in a modest improvement in model discrimination, compared with the inclusion of either one alone. Among participants with impaired fasting glucose/impaired glucose tolerance (IFG/IGT) at baseline, hsCRP and adiponectin levels were not predictive of progression or improvement of glycaemic status. Conclusions/interpretation: Adiponectin and hsCRP levels are independent factors in predicting the deterioration of glycaemia, supporting the role of adiposity-related inflammation in the development of type 2 diabetes. Their combined use as predictive biomarkers is especially useful in women, but not in participants with IFG/IGT. © 2011 The Author(s).<br />published_or_final_version<br />Springer Open Choice, 21 Feb 2012
- Subjects :
- Adult
Blood Glucose
Male
medicine.medical_specialty
Endocrinology, Diabetes and Metabolism
Combined use
030209 endocrinology & metabolism
030204 cardiovascular system & hematology
Biology
Gastroenterology
Article
C-reactive protein
03 medical and health sciences
0302 clinical medicine
Sex Factors
Sex factors
Internal medicine
Glucose Intolerance
Internal Medicine
medicine
Humans
Prospective Studies
10. No inequality
Prospective cohort study
Proportional Hazards Models
Adiponectin
Proportional hazards model
nutritional and metabolic diseases
Human physiology
Biomarker
Middle Aged
3. Good health
Endocrinology
biology.protein
Biomarker (medicine)
Female
Glycaemia
hormones, hormone substitutes, and hormone antagonists
Biomarkers
Subjects
Details
- Language :
- English
- ISSN :
- 14320428 and 0012186X
- Volume :
- 54
- Issue :
- 10
- Database :
- OpenAIRE
- Journal :
- Diabetologia
- Accession number :
- edsair.doi.dedup.....fe0df001c8077496afaf3f81b08abca5